EAACI Congress 2023
BackAsthma 1
Friday 09 Jun, 12:00 PM -
13:00 PM CEST
Poster Zone C
Posters
12:00
Airway and airspace lesions in eosinophilic granulomatosis with polyangiitis
12:00
Automating online participant selection for clinical trials in allergen immunotherapy
12:00
CSN5 is a circulating marker for asthma exacerbation
12:00
Early response to dupilumab in patients with and without previous biologic treatment
12:00
Effect of inhalation formulation on bronchial obstruction in teen-aged asthmatics
12:00
Effect of preconceptional paternal e-nicotine on F1 development in Drosophila melanogaster
12:00
Farm-dust mediated upregulation of activated B-cells in asthmatic and healthy children
12:00
Mold immunotherapy; real world evidence with a cluster schedule
12:00
Potential Allergenic Properties of Erysiphe palczewskii & Erysiphe convolvuli – in vitro Studies
12:00
Risk factors of NSAID-exacerbated respiratory disease: A population-based study
12:00
Study of the effectiveness of the Connect 360 Program for the control of our asthmatic Benralizumab treated patients
12:00
T regulatory and Th17 Cells in Atopic Dermatitis and Allergic Asthma
12:00
The Effect of an Educational Program for Children with Asthma on Airway Inflammation: Before and During the COVID-19 pandemic
12:00
The Inflammasome Inhibitor OLT1177 Improves Experimental Allergic Asthma in Mice
12:00
The role of p300 in the pathogenesis of allergic asthma
12:00
Use of leukotriene-receptor antagonists during pregnancy and risk of neuropsychiatric events in offspring
